Ebola: The unexpected emerging disease;Ebola: Le point au crépuscule d'une épidémie inattendue

Revue Medicale Suisse

Volumn 11, Issue 470, 2015, Pages 877-883

  Vetter, P ^a   Schibler, M ^a   Dayer, J A ^a   Kaiser, L ^a,b  

^a Centre Collaboratif Suisse de Référence pour les Maladies Virales Émergentes   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

ARTICLE; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EPIDEMIC; EXPERIMENTAL THERAPY; NONHUMAN; VIRUS CHARACTERIZATION; COMMUNICABLE DISEASES, EMERGING; HEALTH; HEMORRHAGIC FEVER, EBOLA; HUMAN;

COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; GLOBAL HEALTH; HEMORRHAGIC FEVER, EBOLA; HUMANS;

EID: 84928159869     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978;56:271-93.
2. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ 1978;56:247-70.
3. Kanapathipillai R. Ebola virus disease - current knowledge. New Engl J Med 2014;371:e18.
4. WHO. Ebola response roadmap situation report. Geneva: World Health Organization, 2015 http://apps. who.int/ebola/en/ebola-situation-report/situation-reports/ebola-situation-report-18-february-2015
5. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014;345:1369-72.
6. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. New Engl J Med 2014;371:1418-25.
7. Parra JM, Salmeron OJ, Velasco M. The first case of Ebola virus disease acquired outside Africa. New Engl J Med 2014;371:2439-40.
8. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gramnegative septicemia. New Engl J Med 2014;371:2394-401.
9. Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. New Engl J Med 2014;371:2402-9.
10. Wolf T, Kann G, Becker S, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: Treatment of a patient in intensive care. Lancet 2014; epub ahead of print.
11. Maganga GD, Kapetshi J, Berthet N, et al. Ebola virus disease in the Democratic Republic of Congo. New Engl J Med 2014;371:2083-91.
12. Sanchez A, Geisbert TW, Feldmann H. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams & Wilkins, 2006:1409-48.
13. Piercy TJ, Smither SJ, Steward JA, Eastaugh L, Lever MS. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010;109:1531-9.
14. World Health Organization (2014). Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings wfoE, www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf
15. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005;438:575-6.
16. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196(Suppl. 2):S142-7.
17. Dowell SF, Mukunu R, Ksiazek TG, et al. Transmission of Ebola hemorrhagic fever: A study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999;179(Suppl. 1):S87-91.
18. Roels TH, Bloom AS, Buffington J, et al. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: Risk factors for patients without a reported exposure. J Infect Dis 1999;179(Suppl. 1):S92-7.
19. Formenty P, Leroy EM, Epelboin A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006;42:1521-6.
20. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl. 1):S170-6.
21. Alimonti J, Leung A, Jones S, et al. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci Rep 2014;4:5824.
22. Jaax N, Jahrling P, Geisbert T, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995;346:1669-71.
23. Johnson E, Jaax N, White J, Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995;76:227-36.
24. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 2015;235:153-74.
25. Osterholm MT, Moore KA, Kelley NS, et al. Transmission of ebola viruses: What we know and what we do not know. MBio 2015;6.
26. Team WHOER. Ebola virus disease in West Africa - the first 9 months of the epidemic and forward projections. New Engl J Med 2014;371:1481-95.
27. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003;163:2347-70.
28. Hensley LE, Jones SM, Feldmann H, Jahrling PB, Geisbert TW. Ebola and Marburg viruses: Pathogenesis and development of countermeasures. Curr Mol Med 2005;5:761-72.
29. Zaki SR, Goldsmith CS. Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999;235:97-116.
30. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011;377:849-62.
31. Rougeron V, Feldmann H, Grard G, Becker S, Leroy EM. Ebola and Marburg haemorrhagic fever. J Clin Virol 2015;64:111-9.
32. Audet J, Kobinger GP. Immune evasion in ebolavirus infections. Viral Immunol 2015;28:10-8.
33. Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000;355:2210-5.
34. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. New Engl J Med 2015;372:40-7.
35. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients. J Infect Dis 1999;179(Suppl. 1):S1-7.
36. Chertow DS, Kleine C, Edwards JK, et al. Ebola virus disease in West Africa - clinical manifestations and management. New Engl J Med 2014;371:2054-7.
37. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. New Engl J Med 2014;371:2092-100.
38. Dallatomasina S, Crestani R, Sylvester Squire J, et al. Ebola outbreak in rural West Africa: Epidemiology, clinical features and outcomes. Trop Med Int Health 2015; epub ahead of print.
39. Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 1999;179(Suppl. 1):S13-4.
40. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Diseases 1999;179(Suppl. 1):S28-35.
41. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011;204(Suppl. 3):S810-6.
42. Schibler M, Vetter P, Cherpillod P, et al. Clinical features and viral kitetics in a rapidly cured Ebola virus disease case (submitted).
43. Baggi FM, Taybi A, Kurth A, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Euro Surv 2014;19.
44. Sobarzo A, Eskira Y, Herbert AS, et al. Immune memory to Sudan virus: Comparison between two separate disease outbreaks. Viruses 2015;7:37-51.
45. Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014;514:47-53.
46. Oestereich L, Ludtke A, Wurr S, et al. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 2014;105:17-21.
47. Geisbert TW, Daddario-Dicaprio KM, Geisbert JB, et al. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine 2008;26:6894-900.
48. Ledgerwood JE, DeZure AD, Stanley DA, et al. Chimpanzee Adenovirus Vector Ebola vaccine - preliminary report. New Engl J Med 2014; epub ahead of print.
49. Rampling T, Ewer K, Bowyer G, et al. A Monovalent Chimpanzee Adenovirus Ebola vaccine - preliminary report. New Engl J Med 2015, epub ahead of print.
50. Faye O, Boelle PY, Heleze E, et al. Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: An observational study. Lancet Infect Dis 2015; epub ahead of print.